Kiriakidou M, Ching CL (2020) Systemic lupus erythematosus. Ann Intern Med 172(11):ITC81–ITC96

Article  PubMed  Google Scholar 

Lubon W, Lubon M, Kotyla P et al (2022) Understanding ocular findings and manifestations of systemic lupus erythematosus: update review of the literature. Int J Mol Sci 23(20)

Lythgoe H, Lj M, Hedrich CM et al (2022) Classification of systemic lupus erythematosus in children and adults. Clin Immunol 234:108898

Article  CAS  PubMed  Google Scholar 

(2021) Chinese guidelines for the diagnosis and treatment of childhood-onset systemic lupus erythematosus. Zhonghua Er Ke Za Zhi 59(12):1009–1024

(2018) Evidence-based guideline on diagnosis and treatment of lupus nephritis (2016). Zhonghua Er Ke Za Zhi 56(2):88–94

Nandakumar KS, Nundel K (2022) Editorial: Systemic lupus erythematosus—predisposition factors, pathogenesis, diagnosis, treatment and disease models. Front Immunol 13:1118180

Article  PubMed  PubMed Central  Google Scholar 

Wang R, Wang M, Xia Z et al (2021) Long-term renal survival and related risk factors for primary membranous nephropathy in Chinese children: a retrospective analysis of 217 cases. J Nephrol 34(2):589–596

Article  CAS  PubMed  Google Scholar 

Parodis I, Lindblom J, Tsoi A et al (2024) Trajectories of disease evolution upon treatment initiation in systemic lupus erythematosus: results from four clinical trials of belimumab. Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/keae575

Article  PubMed  Google Scholar 

Alexander T, Hedrich CM (2022) Systemic lupus erythematosus—are children miniature adults? Clin Immunol 234:108907

Article  CAS  PubMed  Google Scholar 

Furie R, Rovin BH, Houssiau F et al (2022) Safety and efficacy of belimumab in patients with lupus nephritis: open-label extension of BLISS-LN study. Clin J Am Soc Nephrol 17(11):1620–1630

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rovin BH, Furie R, Teng Y et al (2022) A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis. Kidney Int 101(2):403–413

Article  CAS  PubMed  Google Scholar 

Brunner HI, Abud-Mendoza C, Viola DO et al (2020) Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial. Ann Rheum Dis 79(10):1340–1348

Article  CAS  PubMed  Google Scholar 

Pluss M, Piantoni S, Tampe B et al (2022) Belimumab for systemic lupus erythematosus—focus on lupus nephritis. Hum Vaccin Immunother 18(5):2072143

Article  PubMed  PubMed Central  Google Scholar 

Guzman M, Hui-Yuen JS (2020) Management of pediatric systemic lupus erythematosus: focus on belimumab. Drug Des Dev Ther 14:2503–2513

Article  CAS  Google Scholar 

Poddighe D, Van Nguyen AT, Phung LT et al (2025) Innovative therapies for childhood-onset systemic lupus erythematosus. World J Pediatr 21:0

National Clinical Research Center for Dermatologic and Immunologic Diseases; Chinese Systemic Lupus Erythematosus Treatment and Research Group; Chinese Rheumatology Association (2025) Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus (2025 edition). Zhonghua Yi Xue Za Zhi 105(23):1879–1906 (Chinese)

Navarra SV, Guzman RM, Gallacher AE et al (2011) Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 377(9767):721–731

Article  CAS  PubMed  Google Scholar 

Urowitz MB, Aranow C, Asukai Y et al (2022) Impact of belimumab on organ damage in systemic lupus erythematosus. Arthritis Care Res (Hoboken) 74(11):1822–1828

Article  CAS  PubMed  Google Scholar 

Struemper H, Chen C, Cai W (2013) Population pharmacokinetics of belimumab following intravenous administration in patients with systemic lupus erythematosus. J Clin Pharmacol 53(7):711–720

Article  PubMed  Google Scholar 

Gong Y, Liu S, Liu H, Shi Y, Li Y, Guan W, Zeng Q, Lv Q, Zhang X, Wei Q, Chen J, Shen Q, Xu H, Sun L (2024) Efficacy of initial combination with belimumab in newly diagnosed childhood-onset lupus nephritis: a single-centre historical control study. Lupus Sci Med 11(2):e001350

Article  PubMed  PubMed Central  Google Scholar 

Kang M, Zhu J, Xu YJ, Li SN, Lai JM (2022) Efficacy and safety of belimumab treatment in childhood-onset systemic lupus erythematosus. Zhonghua Yi Xue Za Zhi 102(48):3881–3885. https://doi.org/10.3760/cma.j.cn112137-20220302-00438. (Chinese)

Article  CAS  PubMed  Google Scholar 

Singh JA, Shah NP, Mudano AS (2021) Belimumab for systemic lupus erythematosus. Cochrane Database Syst Rev 2(2):CD10668

Google Scholar 

Zhang F, Bae SC, Bass D et al (2018) A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea. Ann Rheum Dis 77(3):355–363

Article  CAS  PubMed  Google Scholar